Karuna Therapeutics Inc. (KRTX) Misses Q4 EPS by 33c

Karuna Therapeutics Inc. (NASDAQ: KRTX) reported Q4 EPS of ($3.01), $0.33 worse than the analyst estimate of ($2.68).

For earnings history and earnings-related data on Karuna Therapeutics Inc. (KRTX) click here.

You May Also Be Interested In

• Blue Owl leads $2.4 billion debt deal for Iren data center
• Jiayin Group (JFIN) Reports Q2 Loss of RMB3.56
• Benchmark Reiterates Buy Rating on Malibu Boats (MBUU) on Significant Earnings Upside